Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balch, C. M.
Right arrow Articles by Harrison, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balch, C. M.
Right arrow Articles by Harrison, R.
Related Collections
Right arrow Surgery

Annals of Surgical Oncology, Vol 7, Issue 2 87-97, Copyright © 2000 by Society of Surgical Oncology

ARTICLES

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial

C. M. Balch, S. Soong, M. I. Ross, M. M. Urist, C. P. Karakousis, W. J. Temple, M. C. Mihm, R. L. Barnhill, W. R. Jewell, H. J. Wanebo and R. Harrison
cmbalch@aol.com

BACKGROUND: Ten- to 15-year survival results were analyzed from a prospective multi-institutional randomized surgical trial that involved 740 stages I and II melanoma patients with intermediate thickness melanomas (1.0 to 4.0 mm) and compared elective (immediate) lymph node dissection (ELND) with clinical observation of the lymph nodes as well as prognostic factors that independently predict outcomes. METHODS: Eligible patients were stratified according to tumor thickness, anatomical site, and ulceration, and then prerandomized to either ELND or nodal observation. By using Cox stepwise multivariate regression analysis, the independent predictors of outcome were tumor thickness (P < .001), the presence of tumor ulceration (P < .001), trunk site (P = .003), and patient age more than 60 years (P = .01). RESULTS: Overall 10-year survival was not significantly different for patients who received ELND or nodal observation (77% vs. 73%; P = .12). Among the prospectively stratified subgroups of patients, 10-year survival rates favored those patients with ELND, with a 30% reduction in mortality rate for the 543 patients with nonulcerated melanomas (84% vs. 77%; P = .03), a 30% reduction in mortality rate for the 446 patients with tumor thickness of 1.0 to 2.0 mm (86% vs. 80%; P = .03), and a 27% reduction in mortality rate for 385 patients with limb melanomas (84% vs. 78%; P = .05). Of these subgroups, the presence or absence of ulceration should be the key factor for making treatment recommendations with regard to ELND for patients with intermediate thickness melanomas. CONCLUSIONS: These long-term survival rates from patients treated at 77 institutions demonstrate that ulceration and tumor thickness are dominant predictive factors that should be used in the staging of stages I and II melanomas, and confer a survival advantage for these subgroups of prospectively defined melanoma patients.


This article has been cited by other articles:


Home page
 Arch SurgHome page
B. E. Wright, R. P. Scheri, X. Ye, M. B. Faries, R. R. Turner, R. Essner, and D. L. Morton
Importance of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma
Arch Surg, September 1, 2008; 143(9): 892 - 900.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
Z. I. Nowecki, P. Rutkowski, and W. Michej
The Survival Benefit to Patients with Positive Sentinel Node Melanoma After Completion Lymph Node Dissection May Be Limited to the Subgroup with a Primary Lesion Breslow Thickness Greater Than 1.0 and Less Than or Equal to 4 mm (pT2-pT3)
Ann. Surg. Oncol., August 1, 2008; 15(8): 2223 - 2234.
[Abstract] [Full Text] [PDF]

Home page
 J Ultrasound MedHome page
K. R. Nielsen, H. S. Grossjohann, C. P. Hansen, and M. B. Nielsen
Use of Contrast-Enhanced Ultrasound Imaging to Detect the First Draining Lymph Node (FDLN) in a Swine Model: Correlation of Imaging Findings With the Distance From the Injection Site to the FDLN
J. Ultrasound Med., August 1, 2008; 27(8): 1203 - 1209.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. Y. Bilimoria, C. M. Balch, D. J. Bentrem, M. S. Talamonti, C. Y. Ko, J. R. Lange, D. P. Winchester, and J. D. Wayne
Complete Lymph Node Dissection for Sentinel Node-Positive Melanoma: Assessment of Practice Patterns in the United States
Ann. Surg. Oncol., June 1, 2008; 15(6): 1566 - 1576.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. B. Francken, N. A. Accortt, H. M. Shaw, M. Wiener, S.-j. Soong, H. J. Hoekstra, and J. F. Thompson
Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous Melanoma
Ann. Surg. Oncol., May 1, 2008; 15(5): 1476 - 1484.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. I. Ross and J. E. Gershenwald
How Should We View the Results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?
Ann. Surg. Oncol., March 1, 2008; 15(3): 670 - 673.
[Full Text] [PDF]

Home page
 JCOHome page
C. M. Balch and S.-j. Soong
Predicting Outcomes in Metastatic Melanoma
J. Clin. Oncol., January 10, 2008; 26(2): 168 - 169.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
B. Badgwell, Y. Xing, J. E. Gershenwald, J. E. Lee, P. F. Mansfield, M. I. Ross, and J. N. Cormier
Pelvic Lymph Node Dissection Is Beneficial in Subsets of Patients with Node-positive Melanoma
Ann. Surg. Oncol., October 1, 2007; 14(10): 2867 - 2875.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
J. K. Wall, M. Florero, N. A. Accortt, R. Allen, M. Kashani-Sabet, E. Morita, and S. P. L. Leong
Impact of Multiple Lymphatic Channel Drainage to a Single Nodal Basin on Outcomes in Melanoma
Arch Surg, August 1, 2007; 142(8): 753 - 758.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
F. Tas, S. Kurul, H. Camlica, and E. Topuz
Malignant Melanoma in Turkey: A Single Institution's Experience on 475 Cases
Jpn. J. Clin. Oncol., December 1, 2006; 36(12): 794 - 799.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
D. L. Morton, J. F. Thompson, A. J. Cochran, N. Mozzillo, R. Elashoff, R. Essner, O. E. Nieweg, D. F. Roses, H. J. Hoekstra, C. P. Karakousis, et al.
Sentinel-node biopsy or nodal observation in melanoma.
N. Engl. J. Med., September 28, 2006; 355(13): 1307 - 1317.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. M. Balch and N. Cascinelli
Sentinel-Node Biopsy in Melanoma
N. Engl. J. Med., September 28, 2006; 355(13): 1370 - 1371.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
J. B. McHugh, L. Su, K. A. Griffith, J. L. Schwartz, S. L. Wong, V. Cimmino, A. E. Chang, T. M. Johnson, and M. S. Sabel
Significance of Multiple Lymphatic Basin Drainage in Truncal Melanoma Patients Undergoing Sentinel Lymph Node Biopsy
Ann. Surg. Oncol., September 1, 2006; 13(9): 1216 - 1223.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
T. A. Aloia, J. E. Gershenwald, R. H. Andtbacka, M. M. Johnson, C. W. Schacherer, C. S. Ng, J. N. Cormier, J. E. Lee, M. I. Ross, and P. F. Mansfield
Utility of Computed Tomography and Magnetic Resonance Imaging Staging Before Completion Lymphadenectomy in Patients With Sentinel Lymph Node-Positive Melanoma
J. Clin. Oncol., June 20, 2006; 24(18): 2858 - 2865.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. G. Coit
In-Transit Recurrence After Sentinel Lymph Node Biopsy in Melanoma: Primum Non Nocere
Ann. Surg. Oncol., August 1, 2005; 12(8): 575 - 578.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
T. M. Pawlik, M. I. Ross, M. M. Johnson, C. W. Schacherer, D. M. McClain, P. F. Mansfield, J. E. Lee, J. N. Cormier, and J. E. Gershenwald
Predictors and Natural History of In-Transit Melanoma After Sentinel Lymphadenectomy
Ann. Surg. Oncol., August 1, 2005; 12(8): 587 - 596.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. van Poll, J. F. Thompson, M. H. Colman, J. G. McKinnon, R. P. M. Saw, J. R. Stretch, R. A. Scolyer, and R. F. Uren
A Sentinel Node Biopsy Does Not Increase the Incidence of In-Transit Metastasis in Patients With Primary Cutaneous Melanoma
Ann. Surg. Oncol., August 1, 2005; 12(8): 597 - 608.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
D. R. Berk, D. L. Johnson, A. Uzieblo, M. Kiernan, and S. M. Swetter
Sentinel Lymph Node Biopsy for Cutaneous Melanoma: The Stanford Experience, 1997-2004
Arch Dermatol, August 1, 2005; 141(8): 1016 - 1022.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
V. S.K. Yee, J. F. Thompson, J. G. McKinnon, R. A. Scolyer, L.-X. L. Li, W. H. McCarthy, C. J. O'Brien, M. J. Quinn, R. P.M. Saw, K. F. Shannon, et al.
Outcome in 846 Cutaneous Melanoma Patients From a Single Center After a Negative Sentinel Node Biopsy
Ann. Surg. Oncol., June 1, 2005; 12(6): 429 - 439.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R. E. Jimenez, K. Panageas, K. J. Busam, and M. S. Brady
Prognostic Implications of Multiple Lymphatic Basin Drainage in Patients With Truncal Melanoma
J. Clin. Oncol., January 20, 2005; 23(3): 518 - 524.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. H. Lee, R. Essner, H. Torisu-Itakura, L. Wanek, H. Wang, and D. L. Morton
Factors Predictive of Tumor-Positive Nonsentinel Lymph Nodes After Tumor-Positive Sentinel Lymph Node Dissection for Melanoma
J. Clin. Oncol., September 15, 2004; 22(18): 3677 - 3684.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
U. Leiter, P. G. Buettner, T. K. Eigentler, and C. Garbe
Prognostic Factors of Thin Cutaneous Melanoma: An Analysis of the Central Malignant Melanoma Registry of the German Dermatological Society
J. Clin. Oncol., September 15, 2004; 22(18): 3660 - 3667.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
H. Tsao, M. B. Atkins, and A. J. Sober
Management of Cutaneous Melanoma
N. Engl. J. Med., September 2, 2004; 351(10): 998 - 1012.
[Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
C. M. Balch, S.-J. Soong, M. B. Atkins, A. C. Buzaid, N. Cascinelli, D. G. Coit, I. D. Fleming, J. E. Gershenwald, A. Houghton Jr., J. M. Kirkwood, et al.
An Evidence-based Staging System for Cutaneous Melanoma
CA Cancer J Clin, May 1, 2004; 54(3): 131 - 149.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
N. Elias, K. K. Tanabe, A. J. Sober, M. A. Gadd, M. C. Mihm, B. Goodspeed, and A. B. Cosimi
Is Completion Lymphadenectomy After a Positive Sentinel Lymph Node Biopsy for Cutaneous Melanoma Always Necessary?
Arch Surg, April 1, 2004; 139(4): 400 - 405.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
H. Starz, K. Siedlecki, and B.-R. Balda
Sentinel Lymphonodectomy and S-Classification: A Successful Strategy for Better Prediction and Improvement of Outcome of Melanoma
Ann. Surg. Oncol., March 1, 2004; 11(3_suppl): 162S - 168S.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
O. Alonso, M. Martinez, L. Delgado, A. De Leon, D. De Boni, G. Lago, M. Garces, F. Fontes, J. Espasandin, and J. Priario
Staging of Regional Lymph Nodes in Melanoma Patients by Means of 99mTc-MIBI Scintigraphy
J. Nucl. Med., October 1, 2003; 44(10): 1561 - 1565.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. H. Estourgie, O. E. Nieweg, R. A. Valdes Olmos, C. A. Hoefnagel, and B. B. R. Kroon
Review and Evaluation of Sentinel Node Procedures in 250 Melanoma Patients With a Median Follow-Up of 6 Years
Ann. Surg. Oncol., July 1, 2003; 10(6): 681 - 688.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
J. B. Lowe, E. Hurst, J. F. Moley, and L. A. Cornelius
Sentinel Lymph Node Biopsy in Patients With Thin Melanoma
Arch Dermatol, May 1, 2003; 139(5): 617 - 621.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
R.J.C.L.M. Vuylsteke, P.A.M. van Leeuwen, M.G. S. Muller, H.A. Gietema, D.R. Kragt, and S. Meijer
Clinical Outcome of Stage I/II Melanoma Patients After Selective Sentinel Lymph Node Dissection: Long-Term Follow-Up Results
J. Clin. Oncol., March 15, 2003; 21(6): 1057 - 1065.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
M. E. Reeves, R. Delgado, K. J. Busam, M. S. Brady, and D. G. Coit
Prediction of Nonsentinel Lymph Node Status in Melanoma
Ann. Surg. Oncol., January 1, 2003; 10(1): 27 - 31.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
M. B. Lens, M. Dawes, T. Goodacre, and J. A. Newton-Bishop
Elective Lymph Node Dissection in Patients With Melanoma: Systematic Review and Meta-analysis of Randomized Controlled Trials
Arch Surg, April 1, 2002; 137(4): 458 - 461.
[Abstract] [Full Text] [PDF]

Home page
 Arch SurgHome page
R. J Bold
Elective Lymph Node Dissection in Patients With Melanoma--Invited Critique
Arch Surg, April 1, 2002; 137(4): 461 - 461.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
K. M. McMasters, S. L. Wong, M. J. Edwards, C. Chao, M. I. Ross, R. D. Noyes, V. Viar, P. B. Cerrito, and D. S. Reintgen
Frequency of Nonsentinel Lymph Node Metastasis in Melanoma
Ann. Surg. Oncol., March 1, 2002; 9(2): 137 - 141.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
S. Dessureault, S.-J. Soong, M. I. Ross, J. F. Thompson, J. M. Kirkwood, D. G. Coit, K. M. McMasters, C. M. Balch, and D. Reintgen
Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node Biopsy
Ann. Surg. Oncol., December 1, 2001; 8(10): 766 - 770.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. M. Balch, S.-J. Soong, J. E. Gershenwald, J. F. Thompson, D. S. Reintgen, N. Cascinelli, M. Urist, K. M. McMasters, M. I. Ross, J. M. Kirkwood, et al.
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
J. Clin. Oncol., August 15, 2001; 19(16): 3622 - 3634.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. M. Balch, A. C. Buzaid, S.-J. Soong, M. B. Atkins, N. Cascinelli, D. G. Coit, I. D. Fleming, J. E. Gershenwald, A. Houghton Jr, J. M. Kirkwood, et al.
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
J. Clin. Oncol., August 15, 2001; 19(16): 3635 - 3648.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
K. M. McMasters, D. S. Reintgen, M. I. Ross, J. E. Gershenwald, M. J. Edwards, A. Sober, N. Fenske, F. Glass, C. M. Balch, and D. G. Coit
Sentinel Lymph Node Biopsy for Melanoma: Controversy Despite Widespread Agreement
J. Clin. Oncol., June 1, 2001; 19(11): 2851 - 2855.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
C. M. Balch, S.-j. Soong, T. Smith, M. I. Ross, M. M. Urist, C. P. Karakousis, W. J. Temple, M. C. Mihm, R. L. Barnhill, W. R. Jewell, et al.
Long-Term Results of a Prospective Surgical Trial Comparing 2 cm vs. 4 cm Excision Margins for 740 Patients With 1-4 mm Melanomas
Ann. Surg. Oncol., March 1, 2001; 8(2): 101 - 108.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
I. Pidhorecky, R. J. Lee, G. Proulx, D. R. Kollmorgen, C. Jia, D. L. Driscoll, W. G. Kraybill, and J. F. Gibbs
Risk Factors for Nodal Recurrence After Lymphadenectomy for Melanoma
Ann. Surg. Oncol., March 1, 2001; 8(2): 109 - 115.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. Cady
Sentinel Lymph Node Procedure in Squamous Cell Carcinoma of the Vulva
J. Clin. Oncol., August 15, 2000; 18(15): 2795 - 2797.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.